cPMP substrate replacement therapy drugs are used to treat Molybdenum Cofactor Deficienty Type A, a rare metabolic disease. They work by replacing missing cPMP in the body.
Why are cpmp substrate replacement therapy drugs prescribed?
Cyclic pyranopterin monophosphate (cPMP) substrate replacement therapy is used to treat a genetic condition called molybdenum cofactor deficiency (MoCD) Type A. It work by replacing missing enzymes in the body to help breakdown toxic compounds. An example is Nulibry (fosdenopterin) that's typically infused through the veins.
Prices for popular cPMP Substrate Replacement Therapy Drugs medications
FOSDENOPTERIN treats molybdenum cofactor deficiency (MoCD). It works by replacing a substance normally made by the body, which reduces the buildup of toxins. This reduces injury to the brain.
Disclaimer: Popularity is based on total prescriptions for the brand and generic versions of each drug, regardless of the condition being treated. Some drugs are prescribed for multiple conditions.
Subscribe and save
Get prescription saving tips and more from GoodRx Health. Enter your email to sign up